News Grower

Independent coverage of AI, startups, and technology.

Ars Technica Mar 20, 2026 at 17:36 Big Tech Stable Warm

RFK may replace entire panel of CDC vaccine advisors again, ally lets slip

Robert Malone made the claim, then retracted it, as HHS denied it.

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Beth Mole Original source
RFK may replace entire panel of CDC vaccine advisors again, ally lets slip

A member of an influential federal vaccine advisory panel made a dramatic claim Thursday afternoon that the panel had been disbanded following a temporary block by a federal judge and would be entirely reconstituted—again. But, just hours later, he retracted the claim, saying that it was merely a possibility. The claim immediately caused a stir online. Public health experts began to cheer the news, given that most of the current members hold anti-vaccine views and have little to no qualifications for being on the panel—which is the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP). Current members were hand-selected by anti-vaccine health Secretary Robert F. Kennedy Jr., who had summarily fired all 17 experts previously on ACIP. Kennedy's new ACIP members have since held several chaotic meetings in which they voted to roll-back CDC's evidence-based vaccine guidance. On Monday, Federal Judge Brian Murphy issued a temporary injunction blocking Kennedy's ACIP members and their votes after finding that they were improperly appointed and vaccine recommendations were changed without procedural requirements. The ruling stemmed from a lawsuit brought by the American Academy of Pediatrics (AAP) and other medical groups, who challenged Kennedy's anti-vaccine efforts. Read full article Comments

Stay on the signal

Follow RFK may replace entire panel of CDC vaccine advisors again, ally lets slip

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Advisors, Advisors Again, and Ars Technica, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 22, 2026 at 21:52 Ars Technica

GM installs robots at flagship EV factory after laying off 1,300 workers

US autoworkers union warns of robot automation as dark factory future looms.

Jun 22, 2026 at 21:02 Ars Technica

Man used massage gun on his tired eyeballs. It went as well as you'd expect.

He had retinal tears and bruises from squishing his eyeballs with the gun.

Jun 22, 2026 at 20:10 Ars Technica

Polymarket's viral videos showed people winning big, but the bets were fake

"Winning" bets were made on cloned website and would have lost money, WSJ finds.

Jun 22, 2026 at 19:16 Ars Technica

Following user outcry, AMD reinstates memory encryption in consumer CPUs

Critics saw the move as an underhanded way to steer them toward more costly chips.

Jun 22, 2026 at 19:02 Ars Technica

Valve's Steam Machine ships June 29 for $1,049, but you probably won't be able to buy one yet

Valve says it's using a randomized purchase queue to make the experience "less frustrating and more fair."

Mar 20, 2026 at 17:36 Ars Technica

RFK may replace entire panel of CDC vaccine advisors again, ally lets slip

Robert Malone made the claim, then retracted it, as HHS denied it.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page